|
Senseonics Leads Development Efforts of a Long-Term “Artificial Pancreas” System for Use in the International Diabetes Closed Loop Trial
07/24/2017
|
|
|
Senseonics Announces Pricing of $41 Million Underwritten Offering of Common Stock
05/26/2017
|
|
|
Senseonics to Present at the B. Riley & Co. Institutional Investor Conference
05/18/2017
|
|
|
Senseonics and TypeZero Sign Development Agreement for Artificial Pancreas and Decision Support Systems
05/11/2017
|
|
|
Senseonics Holdings, Inc. Reports First Quarter 2017 Financial Results
05/04/2017
|
|
|
Senseonics Appoints Michael J. Gill, Vice President of Sales
04/19/2017
|
|
|
Senseonics Holdings, Inc. Schedules First Quarter 2017 Earnings Release and Conference Call for May 4, 2017 at 4:30 p.m. Eastern Time
04/18/2017
|
|
|
Senseonics Draws Third Tranche of Existing Loan Facility
03/30/2017
|
|
|
Senseonics to Present at the Raymond James 38th Annual Institutional Investors Conference
02/27/2017
|
|
|
Senseonics Holdings, Inc. Reports Fourth Quarter 2016 Financial Results
02/23/2017
|
|